medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2012; 11 (1)


Amoebic liver abscess production by Entamoeba dispar

Dolabella SS, Serrano-Luna J, Navarro-García F, Cerritos R, Ximénez C, Galván-Moroyoqui JM, Silva EF, Tsutsumi V, Shibayama M

Idioma: Ingles.
Referencias bibliográficas: 44
Paginas: 107-117
Archivo PDF: 284.30 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sargeaunt PG, Williams JE, Grene JD. The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis. Trans R Soc Trop Med Hyg 1978; 72: 519-21.

  2. Strachan WD, Chiodini PL, Spice WM, Moody AH, Ackers JP. Immunological differentiation of pathogenic and nonpathogenic isolates of Entamoeba histolytica. Lancet 1988; 1: 561-8.

  3. Tannich E, Horstmann RD, Knobloch J, Arnold HH. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci USA 1989; 86: 5118-22.

  4. WHO, Organization WH, PAHO-UNESCO W. Report of a consultation of experts on amoebiasis. Mexico; 1997.

  5. Costa AO, Viana JC, Assis D, Rocha OA, Silva EF. Comparison of xenic and monoxenic Entamoeba dispar cultures using hepatic inoculation in hamster. Arch Med Res 2000; 31(4 Suppl.): S247-S248.

  6. Ximenez C, Cerritos R, Rojas L, Dolabella S, Moran P, Shibayama M, González E, et al. Human amebiasis: breaking the paradigm? Int J Environ Res Public Health 2010; 7: 1105-20.

  7. Mann BJ, Dodson JM, Schroeder JW, Lockhart LA, Leo B, Clark CG. Structure and function of the galactose/N-acetyl D-galactosamine inhibitable adhesin of Entamoeba dispar. Arch Med Res 1997; 28(Spec No.): 168-9.

  8. Petri WA Jr., Smith RD, Schlesinger PH, Murphy CF, Ravdin JI. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest 1987; 80: 1238-44.

  9. Pillai DR, Kobayashi S, Kain KC. Entamoeba dispar: molecular characterization of the galactose/N-acetyl-d-galactosamine lectin. Exp Parasitol 2001; 99: 226-34.

  10. North MJ, Mottram JC, Coombs GH. Cysteine proteinases of parasitic protozoa. Parasitol Today 1990; 6: 270-5.

  11. Reed SL, Keene WE, McKerrow JH, Gigli I. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica. J Immunol 1989; 143: 189-95.

  12. Leippe M. Amoebapores. Parasitol Today 1997; 13: 178-83.

  13. Bhattacharya A, Ghildyal R, Prasad J, Bhattacharya S, Diamond LS. Modulation of a surface antigen of Entamoeba histolytica in response to bacteria. Infect Immun 1992; 60: 1711-3.

  14. Campos-Rodríguez R, Jarillo-Luna A. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity. Parasite Immunol 2005; 27: 1-8.

  15. Meerovitch E, Chadee K. In vivo models for pathogenicity in amebiasis. In: Ravdin J (ed.). Amebiasis Human infection by Entamoeba histolytica. 1988, p. 177-90.

  16. Espinosa-Cantellano M, González-Robles A, Chávez B, Castañon G, Argüello C, Lazaro-Haller A, Martínez-Palomo A. Entamoeba dispar: ultrastructure, surface properties and cytopathic effect. J Eukaryot Microbiol 1998; 45: 265-72.

  17. Costa AO, Gomes MA, Rocha OA, Silva EF. Pathogenicity of Entamoeba dispar under xenic and monoxenic cultivation compared to a virulent E. histolytica. Rev Inst Med Trop Sao Paulo 2006; 48: 245-50.

  18. Furst C, Gomes MA, Tafuri WL, Silva EF. Biological aspects of a Brazilian strain of Entamoeba dispar. Pathologica 2002; 94: 22-7.

  19. Shibayama M, Dolabella SS, Silva EF, Tsutsumi V. A Brazilian species of Entamoeba dispar (ADO) produces amoebic liver abscess in hamsters. Ann Hepatol 2007; 6: 117-8.

  20. Diamond LS, Harlow DR, Cunnick CC. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 1978; 72: 431-2.

  21. Gomes MA, Pesquero JB, Furst C, Valle PR, Pesquero JL, Silva EF. An improved method to distinguish Entamoeba histolytica and Entamoeba dispar. Parasitology 1999; 119: 359-62.

  22. Clark CG, Diamond LS. Differentiation of pathogenic Entamoeba histolytica from other intestinal protozoa by riboprinting. Arch Med Res 1992; 23: 15-6.

  23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.

  24. Clark CG. Axenic cultivation of Entamoeba dispar Brumpt 1925, Entamoeba insolita Geiman and Wichterman 1937 and Entamoeba ranarum Grassi 1879. J Eukaryot Microbiol 1995; 42: 590-3.

  25. Costa CA, De Brito KN, Gomes MA, Caliari MV. Histopathological and immunohistochemical study of the hepatic lesions experimentally induced by Entamoeba dispar. Eur J Histochem 2010; 54: e39.

  26. Brumpt E. Étude sommaire de l’Entamoeba dispar n. sp. Amibe à kystes quadrinucléés, parasite de l’homme. Bull Acad Med 1925; 94: 943-52.

  27. Tsutsumi V, Martinez-Palomo A. Inflammatory reaction in experimental hepatic amebiasis. An ultrastructural study. Am J Pathol 1988; 130: 112-9.

  28. Tsutsumi V, Mena-Lopez R, Anaya-Velazquez F, Martinez- Palomo A. Cellular bases of experimental amebic liver abscess formation. Am J Pathol 1984; 117: 81-91.

  29. Tsutsumi V, Shibayama M. Experimental amebiasis: a selected review of some in vivo models. Arch Med Res 2006; 37: 210-20.

  30. Chadee K, Meerovitch E. The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus). Am J Pathol 1984; 117(1): 71-80.

  31. Orozco ME, Fernandez Castelo S, Martinez Palomo A. Detection of early cellular damage produced by Entamoeba histolytica in epithelia. Arch Invest Med 1982; 13(Suppl. 3): 169-75.

  32. Ravdin JI, Guerrant RL. A review of the parasite cellular mechanisms involved in the pathogenesis of amebiasis. Rev Infect Dis 1982; 4: 1185-207.

  33. Silva EF, Gomes MA, Barral de Martínez AM. Entamoeba histolytica: axenization and characterization of isolated samples from symptomatic and asymptomatic patients from different regions of Brazil. Arch Med Res 1997; 28(Spec No.): 288-9.

  34. Galvan-Moroyoqui JM, Del Carmen Dominguez-Robles M, Franco E, Meza I. The interplay between Entamoeba and enteropathogenic bacteria modulates epithelial cell damage. PLoS Negl Trop Dis 2008; 2: e266.

  35. Talamas-Rohana P, Aguirre-Garcia MM, Anaya-Ruiz M, Rosales- Encina JL. Entamoeba dispar contains but does not secrete acid phosphatase as does Entamoeba histolytica. Exp Parasitol 1999; 92: 219-22.

  36. Padilla-Vaca F, Ankri S, Bracha R, Koole LA, Mirelman D. Down regulation of Entamoeba histolytica virulence by monoxenic cultivation with Escherichia coli O55 is related to a decrease in expression of the light (35-kilodalton) subunit of the Gal/GalNAc lectin. Infect Immun 1999; 67: 2096-102.

  37. Bhattacharya A, Anand MT, Paul J, Yadav N, Bhattacharya S. Molecular changes in Entamoeba histolytica in response to bacteria. J Eukaryot Microbiol 1998; 45: 28S-33S.

  38. Bhattacharya A, Ghildyal R, Prasad J, Bhattacharya S, Diamond LS. Modulation of cell surface antigens of Entamoeba histolytica in response to bacteria. Infec Immun 1992; 60: 711-3.

  39. Bruchhaus I, Loftus BJ, Hall N, Tannich E. The intestinal protozoan parasite Entamoeba histolytica contains 20 cysteine protease genes, of which only a small subset is expressed during in vitro cultivation. Eukaryot Cell 2003; 2: 501-9.

  40. Loftus B, Anderson I, Davies R, Alsmark UC, Samuelson J, Amedeo P, Roncaglia P, et al. The genome of the protist parasite Entamoeba histolytica. Nature 2005; 433: 865-8.

  41. Singh D, Naik SR, Naik S. Role of cysteine proteinase of Entamoeba histolytica in target cell death. Parasitol 2004; 129: 127-35.

  42. Mirelman D, Bracha R, Chayen A, Aust-Kettis A, Diamond LS. Entamoeba histolytica: effect of growth conditions and bacterial associates on isoenzyme patterns and virulence. Exp Parasitol 1986; 62: 142-8.

  43. Mirelman D. Ameba-bacterium relationship in amebiasis. Microbiol Rev 1987; 51: 272-84.

  44. Sepúlveda B, Tanimoto-Weki M, Guerrero A, Solís G. Immunity in hamsters after vaccination with monoxenic acid axenic cultures of E. histolytica. Arch Invest Med 1973; Suppl 1: 159-64.




2020     |     www.medigraphic.com